TRAVERE THERAPEUTICS, INC. Interest Income (Expense), Nonoperating, Net
TRAVERE THERAPEUTICS, INC. (TVTX) reported Interest Income (Expense), Nonoperating, Net of -$2.80 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2024-05-06
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2024-03-31 was -$2.80M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2023-12-31 was -$2.82M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2023-09-30 was -$2.82M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2023-06-30 was -$2.91M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2023 was -$11.33M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2022 was -$11.01M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2021 was -$19.68M.
- TRAVERE THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2020 was -$19.05M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 6 month as first filed | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 9 month as first filed | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -$2.80M 10-Q · filed 2024-05-06 | -$5.62M derived: sum of 2 quarters · filed 2024-05-06 | -$8.44M derived: sum of 3 quarters · filed 2024-05-06 | -$11.35M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2023-12-31 | -$2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$5.64M derived: sum of 2 quarters · filed 2024-02-20 | -$8.55M derived: sum of 3 quarters · filed 2024-02-20 | -$11.33M 10-K · filed 2024-02-20 | ||||
| 2023-09-30 | -$2.82M 10-Q · filed 2023-11-07 | -$5.73M derived: sum of 2 quarters · filed 2023-11-07 | -$8.51M 10-Q · filed 2023-11-07 | -$11.44M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2023-06-30 | -$2.91M 10-Q · filed 2023-08-03 | -$5.85M 10-Q · filed 2023-08-03 | -$8.62M derived: sum of 3 quarters · filed 2024-05-06 | -$11.45M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2023-03-31 | -$2.85M 10-Q · filed 2024-05-06 | -$2.94M 10-Q · filed 2023-05-04 | -$5.71M derived: sum of 2 quarters · filed 2024-05-06 | -$8.54M derived: sum of 3 quarters · filed 2024-05-06 | -$11.51M derived: sum of 4 quarters · filed 2024-05-06 | |||
| 2022-12-31 | -$2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$5.69M derived: sum of 2 quarters · filed 2024-02-20 | -$8.66M derived: sum of 3 quarters · filed 2024-02-20 | -$11.01M 10-K · filed 2024-02-20 | -$11.28M 10-K · filed 2023-02-23 | |||
| 2022-09-30 | -$2.83M 10-Q · filed 2023-11-07 | -$2.89M 10-Q · filed 2022-10-27 | -$5.80M derived: sum of 2 quarters · filed 2023-11-07 | -$8.16M 10-Q · filed 2023-11-07 | -$8.38M 10-Q · filed 2022-10-27 | -$12.93M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-06-30 | -$2.97M 10-Q · filed 2023-08-03 | -$5.49M 10-Q · filed 2023-08-03 | -$10.10M derived: sum of 3 quarters · filed 2024-02-20 | -$15.00M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$2.52M 10-Q · filed 2023-05-04 | -$7.13M derived: sum of 2 quarters · filed 2024-02-20 | -$12.02M derived: sum of 3 quarters · filed 2024-02-20 | -$16.88M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | -$4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$9.51M derived: sum of 2 quarters · filed 2024-02-20 | -$14.36M derived: sum of 3 quarters · filed 2024-02-20 | -$19.68M 10-K · filed 2024-02-20 | -$20.14M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | -$4.90M 10-Q · filed 2022-10-27 | -$9.75M derived: sum of 2 quarters · filed 2022-10-27 | -$15.07M 10-Q · filed 2022-10-27 | -$19.84M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$4.85M 10-Q · filed 2022-08-04 | -$10.17M 10-Q · filed 2022-08-04 | -$14.94M derived: sum of 3 quarters · filed 2023-02-23 | -$19.70M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$5.32M 10-Q · filed 2022-05-05 | -$10.08M derived: sum of 2 quarters · filed 2023-02-23 | -$14.85M derived: sum of 3 quarters · filed 2023-02-23 | -$19.48M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$9.53M derived: sum of 2 quarters · filed 2023-02-23 | -$14.16M derived: sum of 3 quarters · filed 2023-02-23 | -$19.05M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$4.77M 10-Q · filed 2021-10-29 | -$9.40M derived: sum of 2 quarters · filed 2021-10-29 | -$14.29M 10-Q · filed 2021-10-29 | -$18.89M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$4.63M 10-Q · filed 2021-07-29 | -$9.52M 10-Q · filed 2021-07-29 | -$14.12M derived: sum of 3 quarters · filed 2022-02-24 | -$18.67M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$4.89M 10-Q · filed 2021-05-06 | -$9.48M derived: sum of 2 quarters · filed 2022-02-24 | -$14.03M derived: sum of 3 quarters · filed 2022-02-24 | -$18.85M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$9.14M derived: sum of 2 quarters · filed 2022-02-24 | -$13.96M derived: sum of 3 quarters · filed 2022-02-24 | -$18.83M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$4.55M 10-Q · filed 2020-11-05 | -$9.36M derived: sum of 2 quarters · filed 2020-11-05 | -$14.23M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$4.82M 10-Q · filed 2020-07-31 | -$9.68M 10-Q · filed 2020-07-31 | ||||||
| 2019-03-31 | -$4.87M 10-Q · filed 2020-05-11 | |||||||
| 2018-09-30 | -$2.53M 10-Q · filed 2019-10-30 | -$3.59M derived: sum of 2 quarters · filed 2019-10-30 | -$4.85M 10-Q · filed 2019-10-30 | -$2.62M derived: sum of 4 quarters · filed 2019-10-30 | ||||
| 2018-06-30 | -$1.06M 10-Q · filed 2019-08-06 | -$199.00K 10-Q · filed 2018-08-03 | -$2.21M 10-Q · filed 2019-08-06 | -$557.00K 10-Q · filed 2018-08-03 | -$85.00K derived: sum of 3 quarters · filed 2019-08-06 | -$745.00K derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | -$1.16M 10-Q · filed 2019-05-07 | -$358.00K 10-Q · filed 2018-05-01 | $972.00K derived: sum of 2 quarters · filed 2019-05-07 | $312.00K derived: sum of 3 quarters · filed 2019-05-07 | -$346.00K derived: sum of 4 quarters · filed 2019-05-07 | |||
| 2017-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $1.47M derived: sum of 2 quarters · filed 2018-11-01 | $809.00K derived: sum of 3 quarters · filed 2018-11-01 | -$1.19M 10-K · filed 2018-07-06 | ||||
| 2017-09-30 | -$660.00K 10-Q · filed 2018-11-01 | -$65.00K 10-Q · filed 2017-11-07 | -$1.32M derived: sum of 2 quarters · filed 2018-11-01 | -$3.31M 10-Q · filed 2018-11-01 | -$855.00K 10-Q · filed 2017-11-07 | -$1.60M derived: sum of 4 quarters · filed 2018-11-01 | ||
| 2017-06-30 | -$658.00K 10-Q · filed 2018-08-03 | -$790.00K 10-Q · filed 2018-08-03 | -$940.00K derived: sum of 3 quarters · filed 2018-08-03 | -$1.24M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | -$132.00K 10-Q · filed 2018-07-06 | -$282.00K derived: sum of 2 quarters · filed 2018-07-06 | -$581.00K derived: sum of 3 quarters · filed 2018-07-06 | -$728.00K derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | -$449.00K derived: sum of 2 quarters · filed 2018-07-06 | -$596.00K derived: sum of 3 quarters · filed 2018-07-06 | -$759.00K 10-K · filed 2018-07-06 | ||||
| 2016-09-30 | -$299.00K 10-Q · filed 2017-11-07 | -$446.00K derived: sum of 2 quarters · filed 2017-11-07 | -$609.00K 10-Q · filed 2017-11-07 | -$942.00K derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-06-30 | -$147.00K 10-Q · filed 2017-08-09 | -$309.00K 10-Q · filed 2017-08-09 | -$643.00K derived: sum of 3 quarters · filed 2018-07-06 | -$1.34M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-03-31 | -$163.00K 10-Q · filed 2017-05-05 | -$496.00K derived: sum of 2 quarters · filed 2018-07-06 | -$1.19M derived: sum of 3 quarters · filed 2018-07-06 | -$4.11M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2015-12-31 | -$333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | -$1.03M derived: sum of 2 quarters · filed 2018-07-06 | -$3.95M derived: sum of 3 quarters · filed 2018-07-06 | -$7.75M 10-K · filed 2018-07-06 | ||||
| 2015-09-30 | -$695.00K 10-Q · filed 2016-11-04 | -$3.62M derived: sum of 2 quarters · filed 2016-11-04 | -$7.42M 10-Q · filed 2016-11-04 | -$10.04M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | -$2.92M 10-Q · filed 2016-08-05 | -$6.72M 10-Q · filed 2016-08-05 | -$9.35M derived: sum of 3 quarters · filed 2017-03-01 | -$11.98M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | -$3.80M 10-Q · filed 2016-05-05 | -$3.80M 10-Q · filed 2015-05-11 | -$6.42M derived: sum of 2 quarters · filed 2017-03-01 | -$9.05M derived: sum of 3 quarters · filed 2017-03-01 | -$11.23M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$5.26M derived: sum of 2 quarters · filed 2017-03-01 | -$7.43M derived: sum of 3 quarters · filed 2017-03-01 | -$7.43M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | -$2.63M 10-Q · filed 2015-11-06 | -$2.63M 10-Q · filed 2014-11-13 | -$4.81M derived: sum of 2 quarters · filed 2015-11-06 | -$4.81M 10-Q · filed 2015-11-06 | -$4.81M 10-Q · filed 2014-11-13 | -$4.81M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | -$2.18M 10-Q · filed 2015-08-10 | -$2.18M 10-Q · filed 2015-08-10 | -$2.18M derived: sum of 3 quarters · filed 2016-02-26 | -$2.18M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $536.00 10-Q · filed 2015-05-11 | -$3.91K derived: sum of 2 quarters · filed 2016-02-26 | -$3.91K derived: sum of 3 quarters · filed 2016-02-26 | |||||
| 2013-12-31 | -$4.45K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$4.44K derived: sum of 2 quarters · filed 2016-02-26 | -$46.00K 10-K · filed 2016-02-26 | |||||
| 2013-09-30 | $4.00 10-Q · filed 2014-11-13 | -$41.55K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |